Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Identification of Hymenoptera venom-allergic patients with negative specific IgE to venom extract by using recombinant allergens.

Cifuentes L, Vosseler S, Blank S, Seismann H, Pennino D, Darsow U, Bredehorst R, Ring J, Mempel M, Spillner E, Ollert MW.

J Allergy Clin Immunol. 2014 Mar;133(3):909-10. doi: 10.1016/j.jaci.2013.09.047. Epub 2013 Nov 28. No abstract available.

PMID:
24290287
2.

Api m 10, a genuine A. mellifera venom allergen, is clinically relevant but underrepresented in therapeutic extracts.

Blank S, Seismann H, Michel Y, McIntyre M, Cifuentes L, Braren I, Grunwald T, Darsow U, Ring J, Bredehorst R, Ollert M, Spillner E.

Allergy. 2011 Oct;66(10):1322-9. doi: 10.1111/j.1398-9995.2011.02667.x. Epub 2011 Jun 10.

PMID:
21658068
3.

Generation and epitope analysis of human monoclonal antibody isotypes with specificity for the Timothy grass major allergen Phl p 5a.

Hecker J, Diethers A, Etzold S, Seismann H, Michel Y, Plum M, Bredehorst R, Blank S, Braren I, Spillner E.

Mol Immunol. 2011 May;48(9-10):1236-44. doi: 10.1016/j.molimm.2011.03.005. Epub 2011 Apr 6.

PMID:
21474184
4.

Evaluation of different glycoforms of honeybee venom major allergen phospholipase A2 (Api m 1) produced in insect cells.

Blank S, Michel Y, Seismann H, Plum M, Greunke K, Grunwald T, Bredehorst R, Ollert M, Braren I, Spillner E.

Protein Pept Lett. 2011 Apr;18(4):415-22.

PMID:
21171948
5.

Quantitation of serum IgE by using chimeras of human IgE receptor and avian immunoglobulin domains.

Braren I, Greunke K, Pilette C, Mempel M, Grunwald T, Bredehorst R, Ring J, Spillner E, Ollert M.

Anal Biochem. 2011 May 15;412(2):134-40. doi: 10.1016/j.ab.2010.12.013. Epub 2010 Dec 10.

PMID:
21146489
6.

Recombinant phospholipase A1 (Ves v 1) from yellow jacket venom for improved diagnosis of hymenoptera venom hypersensitivity.

Seismann H, Blank S, Cifuentes L, Braren I, Bredehorst R, Grunwald T, Ollert M, Spillner E.

Clin Mol Allergy. 2010 Apr 1;8:7. doi: 10.1186/1476-7961-8-7.

7.

Identification, recombinant expression, and characterization of the 100 kDa high molecular weight Hymenoptera venom allergens Api m 5 and Ves v 3.

Blank S, Seismann H, Bockisch B, Braren I, Cifuentes L, McIntyre M, Rühl D, Ring J, Bredehorst R, Ollert MW, Grunwald T, Spillner E.

J Immunol. 2010 May 1;184(9):5403-13. doi: 10.4049/jimmunol.0803709. Epub 2010 Mar 26.

8.

Dissecting cross-reactivity in hymenoptera venom allergy by circumvention of alpha-1,3-core fucosylation.

Seismann H, Blank S, Braren I, Greunke K, Cifuentes L, Grunwald T, Bredehorst R, Ollert M, Spillner E.

Mol Immunol. 2010 Jan;47(4):799-808. doi: 10.1016/j.molimm.2009.10.005. Epub 2009 Nov 6.

PMID:
19896717
9.

Recombinant IgY for improvement of immunoglobulin-based analytical applications.

Greunke K, Braren I, Alpers I, Blank S, Sodenkamp J, Bredehorst R, Spillner E.

Clin Biochem. 2008 Oct;41(14-15):1237-44. doi: 10.1016/j.clinbiochem.2008.07.004. Epub 2008 Jul 26.

PMID:
18718459
10.

Establishment of hapten-specific monoclonal avian IgY by conversion of antibody fragments obtained from combinatorial libraries.

Deckers S, Braren I, Greunke K, Meyer N, Rühl D, Bredehorst R, Spillner E.

Biotechnol Appl Biochem. 2009 Jan;52(Pt 1):79-87. doi: 10.1042/BA20080032.

PMID:
18627355
11.

Purification of native and recombinant cobra venom factor using thiophilic adsorption chromatography.

Kölln J, Braren I, Bredehorst R, Spillner E.

Protein Pept Lett. 2007;14(5):475-80.

PMID:
17584174
12.

Comparative expression of different antibody formats in mammalian cells and Pichia pastoris.

Braren I, Greunke K, Umland O, Deckers S, Bredehorst R, Spillner E.

Biotechnol Appl Biochem. 2007 Aug;47(Pt 4):205-14.

PMID:
17373908
13.

Cloning and characterization of dihydrofolate reductase from a facultative alkaliphilic and halotolerant bacillus strain.

Redecke L, Brehm MA, Bredehorst R.

Extremophiles. 2007 Jan;11(1):75-83. Epub 2006 Oct 5.

PMID:
17021659
14.

Inactivation of complement by recombinant human C3 derivatives.

Spillner F, Kölln J, Bredehorst R.

Adv Exp Med Biol. 2006;586:347-60. Review. No abstract available.

PMID:
16893083
15.

Molecular cloning and expression in insect cells of honeybee venom allergen acid phosphatase (Api m 3).

Grunwald T, Bockisch B, Spillner E, Ring J, Bredehorst R, Ollert MW.

J Allergy Clin Immunol. 2006 Apr;117(4):848-54. Epub 2006 Feb 21.

PMID:
16630944
16.

Bivalent monoclonal IgY antibody formats by conversion of recombinant antibody fragments.

Greunke K, Spillner E, Braren I, Seismann H, Kainz S, Hahn U, Grunwald T, Bredehorst R.

J Biotechnol. 2006 Jul 13;124(2):446-56. Epub 2006 Feb 21.

PMID:
16490273
17.

High level expression of monomeric and dimeric human alpha1,3-fucosyltransferase V.

Münster J, Ziegelmüller P, Spillner E, Bredehorst R.

J Biotechnol. 2006 Feb 24;121(4):448-57. Epub 2005 Nov 11.

PMID:
16290306
18.

Immobilized stem-loop structured probes as conformational switches for enzymatic detection of microbial 16S rRNA.

Bockisch B, Grunwald T, Spillner E, Bredehorst R.

Nucleic Acids Res. 2005 Jun 24;33(11):e101.

19.

Engineering of human complement component C3 for catalytic inhibition of complement.

Kölln J, Bredehorst R, Spillner E.

Immunol Lett. 2005 Apr 15;98(1):49-56. Epub 2004 Nov 13.

PMID:
15790508
20.

Comparative analysis of the human and chicken prion protein copper binding regions at pH 6.5.

Redecke L, Meyer-Klaucke W, Koker M, Clos J, Georgieva D, Genov N, Echner H, Kalbacher H, Perbandt M, Bredehorst R, Voelter W, Betzel C.

J Biol Chem. 2005 Apr 8;280(14):13987-92. Epub 2005 Jan 30.

21.

Synthetic human prion protein octapeptide repeat binds to the proteinase K active site.

Georgieva D, Rypniewski W, Echner H, Perbandt M, Koker M, Clos J, Redecke L, Bredehorst R, Voelter W, Genov N, Betzel C.

Biochem Biophys Res Commun. 2004 Dec 24;325(4):1406-11.

PMID:
15555583
22.

Complement inactivation by recombinant human C3 derivatives.

Kölln J, Spillner E, Andrä J, Klensang K, Bredehorst R.

J Immunol. 2004 Nov 1;173(9):5540-5.

23.

Oligomerization of the proteolytic products is an intrinsic property of prion proteins.

Georgieva D, Koker M, Redecke L, Perbandt M, Clos J, Bredehorst R, Genov N, Betzel C.

Biochem Biophys Res Commun. 2004 Oct 29;323(4):1278-86.

PMID:
15451435
24.

Functional analysis of Cobra Venom Factor/human C3 chimeras transiently expressed in mammalian cells.

Kölln J, Matzas M, Jänner N, Mix T, Klensang K, Bredehorst R, Spillner E.

Mol Immunol. 2004 May;41(1):19-28.

PMID:
15140572
25.

Paratope-based protein identification by antibody and peptide phage display.

Spillner E, Deckers S, Grunwald T, Bredehorst R.

Anal Biochem. 2003 Oct 1;321(1):96-104.

PMID:
12963060
26.

Key role of mitochondria in cerulenin-mediated apoptosis.

Heiligtag SJ, Bredehorst R, David KA.

Cell Death Differ. 2002 Sep;9(9):1017-25.

27.

Initial characterization of the apoptosis-inducing receptor for natural human anti-neuroblastoma IgM.

David K, Heiligtag S, Ollert MW, Teppke M, Vogel CW, Bredehorst R.

Med Pediatr Oncol. 2001 Jan;36(1):251-7.

PMID:
11464898
28.

What establishes a protein as an allergen?

Bredehorst R, David K.

J Chromatogr B Biomed Sci Appl. 2001 May 25;756(1-2):33-40. Review.

PMID:
11419725
29.

N-linked oligosaccharides of cobra venom factor contain novel alpha(1-3)galactosylated Le(x) structures.

Gowda DC, Glushka J, Halbeek Hv, Thotakura RN, Bredehorst R, Vogel CW.

Glycobiology. 2001 Mar;11(3):195-208.

PMID:
11320058
31.

[Natural human IgM-antibodies in neuroblastoma therapy: preliminary findings of a phase I/II clinical trial].

Schmitt C, David K, Hiller J, Schrum J, Bredehorst R, Vogel CW, Löliger C, Erttmann R.

Klin Padiatr. 1999 Jul-Aug;211(4):314-8. German.

PMID:
10472569
32.

Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen.

David K, Ollert MW, Vollmert C, Heiligtag S, Eickhoff B, Erttmann R, Bredehorst R, Vogel CW.

Cancer Res. 1999 Aug 1;59(15):3768-75.

33.

Mechanisms of in vivo anti-neuroblastoma activity of human natural IgM.

Ollert MW, David K, Vollmert C, Juhl H, Erttmann R, Bredehorst R, Vogel CW.

Eur J Cancer. 1997 Oct;33(12):1942-8.

PMID:
9516829
34.

Expression of a 260 kDa neuroblastoma surface antigen, the target of cytotoxic natural human IgM: correlation to MYCN amplification and effects of retinoic acid.

David K, Ehrhardt A, Ollert MW, Erttmann R, Bredehorst R, Vogel CW.

Eur J Cancer. 1997 Oct;33(12):1937-41.

PMID:
9516828
35.

Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells.

Juhl H, Petrella EC, Cheung NK, Bredehorst R, Vogel CW.

Immunobiology. 1997 Nov;197(5):444-59.

PMID:
9413745
36.

Assessment of heterogeneity in antibody-antigen displacement reactions.

Rabbany SY, Piervincenzi R, Judd L, Kusterbeck AW, Bredehorst R, Hakansson K, Ligler FS.

Anal Chem. 1997 Jan 15;69(2):175-82.

PMID:
8997894
37.

Naturally occurring humoral cytotoxicity against neuroblastoma (NB) cells in healthy persons and NB patients.

Erttmann R, Schmitt C, Ollert MW, David K, Bredehorst R, Vogel CW.

Pediatr Hematol Oncol. 1996 Nov-Dec;13(6):545-8.

PMID:
8940738
38.

Growth arrest of solid human neuroblastoma xenografts in nude rats by natural IgM from healthy humans.

David K, Ollert MW, Juhl H, Vollmert C, Erttmann R, Vogel CW, Bredehorst R.

Nat Med. 1996 Jun;2(6):686-9.

PMID:
8640561
39.

Normal human serum contains a natural IgM antibody cytotoxic for human neuroblastoma cells.

Ollert MW, David K, Schmitt C, Hauenschild A, Bredehorst R, Erttmann R, Vogel CW.

Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4498-503.

40.

Structure and function of cobra venom factor, the complement-activating protein in cobra venom.

Vogel CW, Bredehorst R, Fritzinger DC, Grunwald T, Ziegelmüller P, Kock MA.

Adv Exp Med Biol. 1996;391:97-114. Review. No abstract available.

PMID:
8726051
41.

Classical complement pathway activation on nucleated cells. Role of factor H in the control of deposited C3b.

Ollert MW, David K, Bredehorst R, Vogel CW.

J Immunol. 1995 Nov 15;155(10):4955-62.

PMID:
7594501
42.

Molecular cloning and derived primary structure of cobra venom factor.

Fritzinger DC, Bredehorst R, Vogel CW.

Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7605. No abstract available.

43.

Cobra venom factor immunoconjugates: effects of carbohydrate-directed versus amino group-directed conjugation.

Zara J, Pomato N, McCabe RP, Bredehorst R, Vogel CW.

Bioconjug Chem. 1995 Jul-Aug;6(4):367-72.

PMID:
7578355
44.

Molecular cloning and derived primary structure of cobra venom factor.

Fritzinger DC, Bredehorst R, Vogel CW.

Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12775-9. Erratum in: Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7605.

45.

Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps.

Ollert MW, Kadlec JV, David K, Petrella EC, Bredehorst R, Vogel CW.

J Immunol. 1994 Sep 1;153(5):2213-21.

PMID:
8051421
46.

Immunoreactivity and function of oligosaccharides in cobra venom factor.

Gowda DC, Petrella EC, Raj TT, Bredehorst R, Vogel CW.

J Immunol. 1994 Mar 15;152(6):2977-86.

PMID:
8144897
47.

Effect of antibody density on the displacement kinetics of a flow immunoassay.

Rabbany SY, Kusterbeck AW, Bredehorst R, Ligler FS.

J Immunol Methods. 1994 Feb 10;168(2):227-34.

PMID:
8308297
48.

Delivery of radionuclides to pretargeted monoclonal antibodies using dihydrofolate reductase and methotrexate in an affinity system.

Hawkins GA, McCabe RP, Kim CH, Subramanian R, Bredehorst R, McCullers GA, Vogel CW, Hanna MG Jr, Pomato N.

Cancer Res. 1993 May 15;53(10 Suppl):2368-73.

49.

Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.

Ollert MW, Kadlec JV, Petrella EC, Bredehorst R, Vogel CW.

Cancer Res. 1993 Feb 1;53(3):592-9.

50.

Kinetics of antibody binding at solid-liquid interfaces in flow.

Wemhoff GA, Rabbany SY, Kusterbeck AW, Ogert RA, Bredehorst R, Ligler FS.

J Immunol Methods. 1992 Dec 8;156(2):223-30.

PMID:
1474258

Supplemental Content

Loading ...
Support Center